Anemia
News
FDA approves new treatment option for rare anemia
Pegcetacoplan (Empaveli) was approved as a treatment for paroxysmal nocturnal hemoglobinuria (PNH).
Commentary
Commentary: Functional assessment developed for older adults with sickle cell disease
Feature
Unique oral drug candidate designed to overcome sickle cell disease
Feature
VEXAS: A novel rheumatologic, hematologic syndrome that’s making waves
News
FDA places clinical hold on sickle cell gene therapy
Conference Coverage
Emotions, worse attention linked to pain-related health care use in SCD
Feature
Landmark sickle cell report targets massive failures, calls for action
Conference Coverage
Survey quantifies COVID-19’s impact on oncology
Oncologists detail how COVID-19 has impacted care, caregivers, continuing medical education, and clinical trials.
From the Journals
Oxidatative stress–related genetic variant tied to stroke risk in sickle cell patients
SOD2 Val16Ala polymorphism may represent a simple and inexpensive alternative for identifying sickle cell patients at risk of stroke.
News
Is anemia due to folate deficiency a myth?
This column includes folate test results from several studies.
News
FDA approves twice-daily formulation of key thalassemia drug